INTERNATIONAL PATENT: JANSSEN PHARMACEUTICALS, INC. FILES APPLICATION FOR "COMBINATION OF MOSNODENVIR AND CLOSE ANALOGS WITH NITD-688 FOR USE IN THE TREATMENT AND PREVENTION OF DENGUE DISEASE"

GENEVA, Dec. 16 -- JANSSEN PHARMACEUTICALS, INC. (1125 TRENTON-HARBOURTON ROADTITUSVILLE, New Jersey 08560) filed a patent application (PCT/IB2025/055655) for "COMBINATION OF MOSNODENVIR AND CLOSE ANALOGS WITH NITD-688 FOR USE IN THE TREATMENT AND PREVENTION OF DENGUE DISEASE" on Jun 02, 2025. With publication no. WO/2025/253267, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GOETHALS, Olivia Gabriella M. (Turnhoutseweg 302340 Beerse), CRABBE, Marjolein (Turnhoutseweg 302340 Beerse), MAKARIADOU, Elli (Turnhoutseweg 30234...